Orders are surging, backlog is stretching into 2028, and the stock is near highs—yet management is still planning around a broken Europe and a China that will not recover.
EMR · Earnings Call · 2026-11-04
Emerson closed fiscal 2026 with the kind of quarter that usually forces analysts to raise numbers. Orders rose 14%, backlog ended at $8.2 billion, up 11%, book-to-bill was 1.01, and adjusted EPS climbed 15% to $1.86. Management guided fiscal 2027 to roughly 5% underlying sales growth and $7.25 of adjusted EPS, up 10%. The stock has already noticed: EMR is up 19.1% over the last 90 trading days and sits near its high. What makes the report interesting is not the strength. It is the gap between the order line and the sales guide—and management's insistence that the gap is real.
Orders are real, but they are stretching into 2028
Lal Karsanbhai did not hedge on demand. “Underlying orders grew 14%... with broad based demand across all business groups.” — Surendralal Lanca Karsanbhai, President and Chief Executive Officer · 2026-11-04 Software and systems orders rose 18%, intelligent devices orders rose 13%, and every region grew, led by North America at 15% and the Middle East at 42%. The project activity is not generic capex. It is concentrated in what Emerson calls growth verticals—power, LNG, life sciences, semiconductor, and aerospace and defense—which grew 21% in 2026 and now represent 27% of sales. The energy security theme is doing real work here: the project funnel rose $600 million to $13 billion, up 17%, and Emerson won roughly $575 million of projects in Q4, 75% from growth verticals. The company cited a Qatar petrochemical complex, LNG Canada Phase 2, and a 10-year DeltaV MES agreement with a global life sciences contract manufacturer. On LNG alone, Karsanbhai framed a ton per annum opportunity: about 100 million tonnes per annum were awarded in 2026, but 275 million tonnes per annum remain.
The catch is timing.
You will see in the 10 K... that has been pretty sticky at 75% for a long time. That dropped to 70%... the order book is filling up with long cycle and that is starting to read through.
That single disclosure explains why a 14% order quarter does not become a 14% sales year. The backlog is real, but it is increasingly back-end loaded. This was already visible three months ago, when Karsanbhai described Ovation orders “reaching into '28 at this point.” — Surendralal Karsanbhai, President and Chief Executive Officer · 2026-08-04 The current call did not change that story; it confirmed it.
The software-renewal ghost finally stops haunting the P&L
For several quarters, Emerson's software narrative was dominated by an accounting headache: the multiyear term-license renewal dynamic that created a $120 million headwind. That theme has now largely vanished from the top of the keyword stack, replaced by broad based demand and project activity. The mechanics are finally turning. CFO Mike Baughman said the renewal dynamic was a 70-basis-point headwind this year and should become roughly a 35-basis-point tailwind in 2027, with the unwind split between 2027 and 2028. This is exactly what management promised on the November 2025 call: “this is a dynamic that will reverse in '27 and '28 relatively ratably over those 2 years.” — Michael Baughman, Chief Financial Officer · 2025-11-05 The current call delivered the first installment: “unwinds roughly half next year, half in 2028.” — Michael J. Baughman, Chief Financial Officer · 2026-11-04
The underlying software business is no longer hiding behind that noise. Annual contract value grew 10.1% to $1.7 billion, and AspenTech synergies reached $100 million—two years ahead of the original integration target. Karsanbhai was notably more specific about Aspen than in prior quarters: new product development in traditional Aspen suites, expansion into DGM, and tighter integration with DeltaV to support what he called the customer journey to an autonomous future. The software contract renewal issue was a real overhang. It is now a fading one.
Europe and China are why the guide looks timid
The conservative 5% sales guide is not a demand problem in the U.S. It is a geography problem. Karsanbhai called it directly: “We have a Europe that continues to... negative performance in 2026... China... continues to be a concerning market for us.” — Surendralal Lanca Karsanbhai, President and Chief Executive Officer · 2026-11-04 Europe was down 1% in fiscal 2026, and management explicitly does not expect an inflection as Germany, France, and Italy remain soft. China is worse structurally. The COO noted that “40% of our sales in China is exposed to petrochemical and refining, and that segment has to new capital formation in a meaningful way, and it is over-capacitized.” — Ram R. Krishnan, Chief Operating Officer · 2026-11-04
That creates a two-speed portfolio. Software and systems grew 14% in Q4, while Intelligent Devices grew only 4%. The European market weakness hits the valve and sensor businesses far harder than the software and systems businesses. Even the semi business—a genuine bright spot, with test and measurement semiconductor orders up 59%—is being modeled cautiously: strong first half, moderating second half on tougher comparisons and a cautious read on the cycle. Prior management commentary said the growth was narrow. In May, Karsanbhai noted “We have not seen tremendous broadening beyond that.” — Surendralal Karsanbhai, President and Chief Executive Officer · 2026-05-05 Today the order language is broader—all business groups, all regions—but the old industrial automation markets are still flat, and the guide reflects that.
Capital return, valuation, and a tape that has stopped paying for AI power at any price
Emerson is returning a lot of cash: roughly $3.8 billion in fiscal 2027, including $2.5 billion of buybacks and $1.3 billion of dividends, with a 7% dividend increase marking the 71st consecutive year of higher payouts. The buyback is front-loaded—about $1.5 billion in Q1—which Baughman said gives “the benefit of the lower share count” — Michael J. Baughman, Chief Financial Officer · 2026-11-04 while preserving flexibility for bolt-on M&A. That is shareholder-friendly, but it also signals that large-scale M&A is not in the plan.
The stock is not cheap. At 24.3x operating income and 4.3x revenue, Emerson has already been re-rated. 24.3x operating income is a full multiple for a company guiding 5% sales growth. The margin story is better: gross margin reached 54.5% in the June quarter, up 1.9pp year over year, with the five-year trend up 12 points. But the tape is sending a warning. The AI data center complex and demand for power trades have weakened over the last 30 days, even as EMR has rallied. Emerson is not a pure data center play—MRO was 63% of Q4 sales and projects 37%—but its growth verticals overlap with the same capex cycle. If the market stops paying for power demand at any price, Emerson's orders can still be real while its multiple compresses.
The story here is a high-quality automation compounder with visible long-cycle orders, a fading software accounting drag, and a management team that is deliberately under-promising on Europe and China. The next proof points are backlog conversion, a stabilization in Intelligent Devices, and whether the order momentum in power and LNG survives the market's growing skepticism toward the AI infrastructure trade.